Studies on the Activity Measurement for Blood Proteases using their Monoclonal Antibodies

用单克隆抗体测定血液蛋白酶活性的研究

基本信息

  • 批准号:
    02557016
  • 负责人:
  • 金额:
    $ 6.02万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
  • 财政年份:
    1990
  • 资助国家:
    日本
  • 起止时间:
    1990 至 1991
  • 项目状态:
    已结题

项目摘要

TISSUE FACTOR POTENTIATES THE HYDROLYSIS OF SYNTHETIC ESTER SUBSTRATE CATALYZED BY FACTOR VIIA.We established a simple and sensitive assay method for the activity of factor VIIa-tissue factor complex using N^<alpha>-benzyloxycarbonyl-L-arginine P-nitrobenzyl ester (Z-Arg-ONb) as a substrate. The substrate has been synthesized previously (Zur, M., and Nemerson, Y. (1978) J. Biol. Chem. 253, 2203-2209). The new method was that the amount of P-nitrobenzyl alcohol released during the enzyme reaction is measured by reversed-phase HPLC, using a 3C_<18> column in 45% acetonitrile containing 0.1% trifluoroacetic acid with an isocratic elution. Z-Arg-ONb had a broad specificity for plasma serine proteases, and factor IXa could hydrolyze this substrate, indicating that the method is also useful for assay of the factor IXa activity. Using this assay method, we examined effect of tissue factor on the esterase activity of factor VIIa under various conditions, and found that tissue factor. . potenti … More ates greatly the hydrolysis of Z-Arg-ONb by both human and bovine factor VIIa's. These results did not agree with the previous report. Moreover, phospholipids were not required for the factor VIIa-mediated hydrolysis of Z-Arg-ONb even in the presence of tissue factor. We also determined the kinetic parameters (Km and kcat) of factor VIIa toward the substrate in the presence or absence of tissue factor. The Km value of factor VIIa alone was 6 times higher than that of factor VIIa-tissue factor complex (3.2 versus 0.54 mM), whereas the kcat value was 12 times lower than that of factor VIIa-tissue factor complex (14.3 ve rsus 173 s^<-1>). These results indicate that tissue factor affects the catalytic center of factor VIIa and enhances the factor VIIa-mediated hydrolysis of the ester substrate. The potentiating effect of tissue factor disappeared by removal of y-carboxyglutamic acid (Gla) -domain from factor VIIa, whereas the esterase activity in the absence of tissue factor was not affected by this modification, suggesting that the Gla-domain is required as the potent determinants on factor VIIa for the interaction with tissue factor, even if phospholipids are absent in the reaction mixture. Less
组织因子促进因子VIIA催化的合成酯底物的水解。我们建立了一种简便、灵敏的测定因子VIIa-组织因子复合体活性的方法,该方法以N^&lt;α&gt;-苄氧甲酰基-L-精氨酸对硝基苄酯(Z-Arg-ONB)为底物。底物以前已经合成过(Zur,M.和Nmerson,Y.(1978)J.Biol)。化学。253、2203-2209)。新的方法是用反相高效液相色谱法测定酶反应过程中释放的对硝基苯甲醇的量,使用3C;lt;18&gt;柱,在含有0.1%三氟乙酸乙腈的45%乙腈中进行等度洗脱。Z-Arg-onb对血浆丝氨酸蛋白酶具有广泛的特异性,并且因子IXa可以对该底物进行水解,这表明该方法也适用于因子IXa活性的测定。用该方法检测了不同条件下组织因子对因子VIIa酯酶活性的影响,发现组织因子对因子VIIa的酯酶活性影响较大。。Potenti…人和牛因子VIIa对Z-Arg-onb的水解率较高,这些结果与以前的报道不一致。此外,即使在组织因子存在的情况下,因子VIIa介导的Z-Arg-onb的水解也不需要磷脂。我们还测定了在存在或不存在组织因子的情况下,因子VIIa朝向底物的动力学参数(Km和kcat)。因子VIIa单独的Km值是因子VIIa-组织因子复合体的6倍(3.2vs0.54 mm),而kcat值则比因子VIIa-组织因子复合体的Km值低12倍(14.3ve RSU 173 S)。这些结果表明,组织因子影响因子VIIa的催化中心,并促进因子VIIa介导的酯底物的水解。去除因子VIIa中的γ-羧基谷氨酸(GLA)结构域后,组织因子的增强作用消失,而在没有组织因子的情况下,酯酶活性不受这种修饰的影响,这表明即使反应混合物中没有磷脂,也需要GLA结构域作为因子VIIa与组织因子相互作用的决定因素。较少

项目成果

期刊论文数量(39)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Morita,T.,et al.: "γ-Carboxyglutamic Acid (Gla)-Domainless Blood Coagulation Factor IXa Species:Preparation and Properties." J.Biochem.110. 990-996 (1991)
Morita, T., et al.:“γ-羧基谷氨酸 (Gla)-无域凝血因子 IXa 物种:制备和特性。J.Biochem.110 (1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Miyata, T. and Iwanaga, S.: Academic Press Inc., Tokyo, New York, London. Recent Advances in Thrombosis and Fibrinolysis Ed. by K. Tanaka) (Molecular Aspects of Extrinsic Blood Coagulation.), (1991)
Miyata, T. 和 Iwanaga, S.:Academic Press Inc.,东京、纽约、伦敦。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
西村 仁,岩永 貞昭: "臨床科学8,内皮細胞シリ-ズ,26巻第3号" 世界保健通信社, 7 (1990)
Hitoshi Nishimura、Sadaaki Iwanaga:“临床科学 8,内皮细胞系列,第 26 卷,第 3 期”《世界健康新闻》,7 (1990)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takaenoki, Y., Muta, T., Miyata, T. and Iwanaga, S.: "cDNA and Amino Acid Sequence of Bovine Tissue Factor." Biochem. Biophys. Res. Communs.181. 1145-1150 (1991)
Takaenoki, Y.、Muta, T.、Miyata, T. 和 Iwanaga, S.:“牛组织因子的 cDNA 和氨基酸序列。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hase, S., Nishimura, H., Kawabata, S., Iwanaga, S. and Ikenaka, T.: "Structure of (Xyl)_2Glc-O-Ser-53 Found in the First Epidermal Growth Factor-like Domain of Bovne Blood Clotting Factor IX." J. Biol. Chem.265(4). 1858-1861 (1990)
Hase, S.、Nishimura, H.、Kawabata, S.、Iwanaga, S. 和 Ikenaka, T.:“在 Bovne 第一个表皮生长因子样结构域中发现的 (Xyl)_2Glc-O-Ser-53 结构
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IWANAGA Sadaaki其他文献

IWANAGA Sadaaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IWANAGA Sadaaki', 18)}}的其他基金

Role of Limulus Hemocytes in the Biological Defense System.
鲎血细胞在生物防御系统中的作用。
  • 批准号:
    04404090
  • 财政年份:
    1992
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Basic studies on Development of Anti-thrombotic Agents
抗血栓药物开发的基础研究
  • 批准号:
    04557015
  • 财政年份:
    1992
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Molecular Mechanism of Extrinsic Blood Coagulation Pathway
外源性凝血途径的分子机制
  • 批准号:
    03044113
  • 财政年份:
    1991
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Mechanism of Hemolymph Coagulation System in Invertebrates
无脊椎动物血淋巴凝固系统的机制
  • 批准号:
    02454539
  • 财政年份:
    1990
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Initiation Mechanism of Extrinsic Blood Coagulation System
外源性凝血系统的启动机制
  • 批准号:
    63044110
  • 财政年份:
    1988
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Development of Synthetic Fluorogenic Peptide Substrates for Blood Clotting Proteases
凝血蛋白酶合成荧光肽底物的开发
  • 批准号:
    63870017
  • 财政年份:
    1988
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
Hemolymph Coagulation and Defence Systems in Invertebrate Animals
无脊椎动物的血淋巴凝固和防御系统
  • 批准号:
    62480453
  • 财政年份:
    1987
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Development and Application of Fluorogenic Peptide Substrates for Determination fo Blood Clotting Proteases
凝血蛋白酶测定荧光肽底物的研制及应用
  • 批准号:
    61880016
  • 财政年份:
    1986
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
Studies on Molecular Abnormality of Blood Coagulation and Fibrinolytic Factors
凝血及纤溶因子分子异常研究
  • 批准号:
    60480497
  • 财政年份:
    1985
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
病原体诱导的血液凝固中脂质过氧化和焦亡诱导的组织因子激活
  • 批准号:
    10571353
  • 财政年份:
    2023
  • 资助金额:
    $ 6.02万
  • 项目类别:
HIV pathology and infection mediated by host-derived tissue factor on the virus: A broad-spectrum antiviral target.
HIV 病理学和病毒上宿主源性组织因子介导的感染:广谱抗病毒靶点。
  • 批准号:
    472183
  • 财政年份:
    2022
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Fellowship Programs
Tissue factor-dependent coagulation in thrombosis and immune responses
血栓形成和免疫反应中的组织因子依赖性凝血
  • 批准号:
    10558720
  • 财政年份:
    2021
  • 资助金额:
    $ 6.02万
  • 项目类别:
Excellence in Research: Molecular mechanism of Tissue Factor encryption and decryption.
卓越研究:组织因子加密和解密的分子机制。
  • 批准号:
    2100878
  • 财政年份:
    2021
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Standard Grant
Host cell-derived tissue factor as a broad-spectrum basis for viral pathology and infection
宿主细胞源性组织因子作为病毒病理学和感染的广谱基础
  • 批准号:
    451461
  • 财政年份:
    2021
  • 资助金额:
    $ 6.02万
  • 项目类别:
    Operating Grants
Tissue factor regulation of receptor tyrosine kinases in glioblastoma
胶质母细胞瘤中受体酪氨酸激酶的组织因子调节
  • 批准号:
    10428642
  • 财政年份:
    2020
  • 资助金额:
    $ 6.02万
  • 项目类别:
Tissue factor regulation of receptor tyrosine kinases in glioblastoma
胶质母细胞瘤中受体酪氨酸激酶的组织因子调节
  • 批准号:
    10304846
  • 财政年份:
    2020
  • 资助金额:
    $ 6.02万
  • 项目类别:
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma
组织因子、连接粘附分子 A 和整合素 B1 之间的相互作用驱动胶质母细胞瘤的自我更新
  • 批准号:
    10331881
  • 财政年份:
    2020
  • 资助金额:
    $ 6.02万
  • 项目类别:
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma
组织因子、连接粘附分子 A 和整合素 B1 之间的相互作用驱动胶质母细胞瘤的自我更新
  • 批准号:
    10554404
  • 财政年份:
    2020
  • 资助金额:
    $ 6.02万
  • 项目类别:
Tissue factor regulation of receptor tyrosine kinases in glioblastoma
胶质母细胞瘤中受体酪氨酸激酶的组织因子调节
  • 批准号:
    10651723
  • 财政年份:
    2020
  • 资助金额:
    $ 6.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了